Select the drug indication to add to your list

Acetylcysteine Solution for Inhalation
Lung surfactants/mucolytics
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

Acetylcysteine Solution for Inhalation Rx

Generic Name and Formulations:
Acetylcysteine 100mg/mL, 200mg/mL; soln for inhalation; preservative-free.

Various generic manufacturers

Therapeutic Use:

Indications for Acetylcysteine Solution for Inhalation:

Adjuvant therapy in patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: chronic bronchopulmonary disease, acute bronchopulmonary disease, pulmonary complications of cystic fibrosis, tracheostomy care, pulmonary complications associated with surgery, use during anesthesia, post-traumatic chest conditions, atelectasis due to mucous obstruction, diagnostic bronchial studies.

Adults and Children:

See literature for administration of aerosol. Nebulization-face mask, mouth piece, tracheostomy: 1–10mL of 20% soln or 2–20mL of 10% soln every 2–6 hours; usual dose: 3–5mL of 20% soln or 6–10mL of 10% soln 3–4 times daily. Nebulization tent, croupette: individualize; requires very large volumes, occasionally as much as 300mL during a single treatment period; recommended dose is the volume of acetylcysteine (using 10% or 20%) that will maintain a very heavy mist for the desired period. Direct instillation: 1–2mL of 10% to 20% soln may be given as often as every hour. Tracheostomy: 1–2mL of 10% or 20% soln every 1–4 hours by instillation into the tracheostomy. Direct instillation into segment of bronchopulmonary tree: Under local anesthesia and direct vision, insert small plastic catheter into trachea; 2–5mL of 20% soln may be instilled by means of syringe connected to catheter. Percutaneous intrathecal catheter: 1–2mL of 20% soln or 2–4mL of 10% soln every 1–4 hours given by syringe attached to catheter. Diagnostic bronchograms: Two or three administrations of 1–2mL of 20% soln or 2–4mL of 10% soln should be given by nebulization or by instillation intratracheally, prior to procedure.


Increased volume of bronchial secretions may occur after administration, airway must be maintained open. Asthma; monitor for bronchospasm; discontinue if occurs. Pregnancy (Cat.B). Nursing mothers.

Pharmacological Class:

Mucolytic agent.


Do not mix with other drugs in nebulizer.

Adverse Reactions:

Stomatitis, GI upset, fever, rhinorrhea, drowsiness, clamminess, chest tightness, bronchoconstriction.


Formerly known under the brand name Mucomyst.

How Supplied:

Contact supplier.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs